Skip to main content
Livermore
Livermore
ZHEN

Brendel Financial Advisors LLC

SEC CIK
0001768065
Latest filing
Jul 31, 2026

The latest 13F from Brendel Financial Advisors LLC covers Q2 2026 (filed Jul 31, 2026): 101 long positions worth $216.0M. The top 10 holdings make up 29.6% of the portfolio, and the largest is Sherwin Williams Co (SHW) at 4.7%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
21
Est. +$24.0M
Added
24
Est. +$4.10M
Reduced
33
Est. −$8.27M
Sold out
15
Est. −$19.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. SHWSherwin Williams Co
    4.7%$10.1MHistory
  2. CATCaterpillar Inc
    4.1%$8.90MHistory
  3. JNJJohnson & Johnson
    3.0%$6.44MHistory
  4. BARGraniteShares Gold Trust
    2.7%$5.80MHistory
  5. ABBVAbbVie Inc.
    2.6%$5.67MHistory

Share of portfolio

Top 5 holdings and the other 96 positions, by share of portfolio value

  1. SHW4.7%
  2. CAT4.1%
  3. JNJ3.0%
  4. BAR2.7%
  5. ABBV2.6%
  6. Other 96 positions82.9%

Biggest buys

New and added positions, by estimated amount bought

  1. WSTWest Pharmaceutical Services Inc
    +$4.27MNewHistory
  2. KOCoca Cola Co
    +$3.67MNewHistory
  3. GNRCGenerac Holdings Inc.
    +$3.22MNewHistory
  4. MNSTMonster Beverage Corp
    +$3.08MNewHistory
  5. LOGILogitech International S.A.
    +$2.89MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. WSTWest Pharmaceutical Services Inc
    +1.98 pp0.0% → 2.0%History
  2. KOCoca Cola Co
    +1.70 pp0.0% → 1.7%History
  3. GNRCGenerac Holdings Inc.
    +1.49 pp0.0% → 1.5%History
  4. MNSTMonster Beverage Corp
    +1.43 pp0.0% → 1.4%History
  5. LOGILogitech International S.A.
    +1.34 pp0.0% → 1.3%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. IBMInternational Business Machines Corp
    −$3.66MReducedHistory
  2. AAAlcoa Corp
    −$3.24MSold outHistory
  3. SWKStanley Black & Decker, Inc.
    −$3.20MSold outHistory
  4. COSTCostco Wholesale Corp
    −$3.09MSold outHistory
  5. First Tr Exchange-Traded FD33734X184
    −$3.06MSold out

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. AAAlcoa Corp
    −1.60 pp1.6% → 0.0%History
  2. SWKStanley Black & Decker, Inc.
    −1.58 pp1.6% → 0.0%History
  3. IBMInternational Business Machines Corp
    −1.53 pp1.9% → 0.4%History
  4. COSTCostco Wholesale Corp
    −1.53 pp1.5% → 0.0%History
  5. First Tr Exchange-Traded FD33734X184
    −1.51 pp1.5% → 0.0%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$216.0M
+$13.9M (+6.9%) vs. prior quarter
Positions
101
+6 vs. prior quarter
Top 10 concentration
29.6%
Top 10 as share of value
Turnover
13.4%
Q2 2026, one quarter
Average holding period
8.2 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $216.0M (Q2 2026)

Q1 2021: $149.3MQ2 2021: $181.8MQ3 2021: $83.8MQ4 2021: $193.0MQ1 2022: $183.9MQ2 2022: $114.8MQ3 2022: $42.1MQ4 2022: $49.9MQ1 2023: $135.2MQ2 2023: $66.4MQ3 2023: $67.4MQ4 2023: $152.7MQ1 2024: $87.4MQ2 2024: $157.3MQ3 2024: $176.4MQ4 2024: $165.4MQ1 2025: $164.6MQ2 2025: $178.5MQ3 2025: $194.8MQ4 2025: $203.4MQ1 2026: $202.1MQ2 2026: $216.0M
Q1 2021Q2 2026
13F filings of Brendel Financial Advisors LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Jul 31, 2026101$216.0MSHWCATJNJvs. Q1 2026SEC
Q1 2026Apr 15, 202695$202.1MSHWBARJNJvs. Q4 2025SEC
Q4 2025Jan 26, 2026100$203.4MSHWBARWMTvs. Q3 2025SEC
Q3 2025Oct 20, 2025102$194.8MSHWBARABBVvs. Q2 2025SEC
Q2 2025Jul 11, 2025101$178.5MSHWCTASBARvs. Q1 2025SEC
Q1 2025Apr 22, 202591$164.6MSHWXOMCTASvs. Q4 2024SEC
Q4 2024Jan 14, 202591$165.4MSHWXOMWMTvs. Q3 2024SEC
Q3 2024Oct 9, 202494$176.4MSHWXOMCTASvs. Q2 2024SEC
Q2 2024Jul 15, 202488$157.3MSHWXOMCTASvs. Q1 2024SEC
Q1 2024Apr 30, 202457$87.4MXOMInvesco Exch Traded FD Tr IICBvs. Q4 2023SEC
Q4 2023Feb 1, 202491$152.7MSHWXOMCTASvs. Q3 2023SEC
Q3 2023Oct 12, 202344$67.4MXOMInvesco Exch Traded FD Tr IICBvs. Q2 2023SEC
Q2 2023Jul 21, 202343$66.4MXOMInvesco Exch Traded FD Tr IIBARvs. Q1 2023SEC
Q1 2023Apr 6, 202383$135.2MSHWXOMPFEvs. Q4 2022SEC
Q4 2022Jan 20, 202336$49.9MXOMSPGIMRKvs. Q3 2022SEC
Q3 2022Oct 11, 202237$42.1MXOMSsga Active ETF TrBARvs. Q2 2022SEC
Q2 2022Jul 26, 202290$114.8MSHWXOMPFEvs. Q1 2022SEC
Q1 2022May 10, 2022113$183.9MSHWPFEXOMvs. Q4 2021SEC
Q4 2021Feb 10, 2022107$193.0MSHWPFECTASvs. Q3 2021SEC
Q3 2021Oct 26, 202155$83.8MFirst Tr Exchange-Traded FDSsga Active ETF TrSPGIvs. Q2 2021SEC
Q2 2021Jul 21, 2021284$181.8MSHWInvesco Exch Traded FD Tr IIFirst Tr Exchange-Traded FDvs. Q1 2021SEC
Q1 2021Apr 14, 202186$149.3MSHWFirst Tr Exchange-Traded FDAmplify ETF Tr–SEC